Is there evidence for mandating electrocardiogram as part of the pre-participation examination?

Clinical Journal of Sport Medicine

Volumn 21, Issue 1, 2011, Pages 13-17

  Borjesson, Mats ^a   Dellborg, Mikael ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cardiac screening; ECG screening; pre participation examination; sudden cardiac death

Indexed keywords

ARTICLE; ATHLETE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH;

ATHLETES; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HUMANS; MANDATORY TESTING; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; SPORTS MEDICINE;

EID: 78651408393     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e318204a7b4     Document Type: Article

References (36)

1. DeBacker G, Ambrosini E, Borch-Johnsen K, et al. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice: European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-1610.
2. Talbot LA, Morrell CH, Fleg JL, et al. Changes in leisure-time physical activity and risk of all-cause mortality in men and women: the Baltimore longitudinal study of aging. Prev Med. 2007;45:169-176.
3. Talbot LA, Morrell C, Metter EJ, et al. Comparison of cardiorespiratory fitness versus leisure-time physical activity as predictors of coronary events in men,65 and .65 years. Am J Cardiol. 2002;89: 1187-1192.
4. Albert CM, Mittleman MA, Chae CU, et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343: 1355-1361.
5. Courson R. Preventing sudden death on the athletic field: the emergency action plan. Curr Sports Med Rep. 2007;6:93-100.
6. Borjesson M, Pelliccia A. Incidence and aetiology of sudden cardiac death in young athletes: an international perspective. Br J Sports Med. 2009;43: 644-648.
7. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42:1959-1963.
8. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516-524.
9. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115:1643-1655.
10. Wilson JMG, Jungner G. Principles and Practice of Screening for Diseases. Geneva, Switzerland: World Health Organisation; 1968.
11. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles. JAMA. 1996; 276:199-204.
12. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol. 1995;75:827-829.
13. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med. 2008;42:207-211.
14. Baggish AL, Hutter AM, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography. Ann Intern Med. 2010;152:269-275.
15. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320.
16. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982;65:1388-1394.
17. Steriotis AK, Bauce B, Daliento L, et al. Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2009; 103:1302-1308.
18. Bauce B, Frigo G, Marcus FI, et al. Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol. 2008;102:1252-1257.
19. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339: 364-369.
20. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation. 1995;92:785-789.
21. Pelliccia A, DiPaolo FM, Corrado D, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006;27:2196-2200.
22. Marcus FI. Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia and Brugada syndrome. J Electrocardiol. 2000;33(suppl):1-10.
23. Wisten A, Andersson S, Forsberg H, et al. Sudden cardiac death in the young in Sweden: electrocardiogram in relation to forensic diagnosis. J Intern Med. 2004;255:213-220.
24. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation. 2000;102: 278-284.
25. Pelliccia A, Fagard R, Bjornstad H, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:1422-1445.
26. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2010;31:243-1259.
27. Corrado D, Biffi A, Basso C, et al. 12-Lead ECG in the athlete: physiological versus pathological abnormalities. Br J Sports Med. 2009; 43:669-676.
28. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256-2262.
29. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008;51:2250-2255.
30. Tanaka Y, Yoshinaga M, Anan R, et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc. 2006;38:2-6.
31. Risser WL, Hoffman HM, Bellah Jr GG, et al. A cost-benefit analysis of preparticipation sports examinations of adolescent athletes. J Sch Health. 1985;55:270-273.
32. Fuller CM. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 2000;32:887-890.
33. MacAuley D. Olympic dreams. Br Med J. 2008;337:a739.
34. Wheeler MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010;152:276-286.
35. Italian Ministry of Health. Rules concerning the medical protection of athletic activity. Gazzetta Ufficiale. 1982;5:63.
36. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med. 2009;43:631-643.